Press-release for stocks for RETA

Prices are updated after-hours

| 80.75% | O: -0.18% H: 0.79% C: -2.78%
CNSP | $0.204 -0.2% -3.49% 130K

| -89.95% | O: -4.52% H: 6.84% C: 4.74%
berubicin treatment pharmaceuticals glioblastoma study

Reata Pharmaceuticals. Announces Closing of Class A Common Stock Offering
Published: 2020-12-04 (Crawled : 20:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0

| 23.34% | O: -0.53% H: 4.05% C: 1.55%
offering

59%

41%

AGBA | News | $1.03 157.5% 57.94% 120M

ZCMD | $1.45 5.84% 52.1% 2.3M

INVO | $1.52 100.0% 51.13% 5M

ISPC | $0.421 97.65% 49.53% 37M

WLGS | News | $0.5 45.65% 470K

OST | $0.509 23.81% 45.26% 90K

GDHG | $0.263 21.76% 40.66% 3.1M

XPON | News | $3.15 63.21% 37.74% 16M

TIRX | $0.8 65.02% 30.74% 58M

BNTC | News | $6.82 42.08% 30.64% 3.5M

Save your searches and get alerts when important news are released.